GlassScriptPhysician profile
Thomas M Swift
NPI 1760571970
$1,622.95
in general payments reported to CMS, 2019-2025
19 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.22 · 2020: $63.96 · 2021: $309 · 2022: $273 · 2023: $488 · 2024: $270 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $251.26 | 2022-2025 | Durysta, Lumigan |
| Bausch & Lomb Americas INC. | $196.05 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Kala Pharmaceuticals, INC. | $137.76 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $131.67 | 2022-2023 | Acthar |
| Oyster Point Pharma, INC. | $128.28 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $95.03 | 2021-2024 | Cequa |
| Aerie Pharmaceuticals, INC. | $83.82 | 2020-2021 | |
| Alcon Vision LLC | $79.98 | 2023-2024 | Clareon, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.17 | 2021 | |
| Horizon Therapeutics Plc | $66.60 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $65.54 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $59.00 | 2022-2025 | Oxervate |
| Allergan, INC. | $54.07 | 2021 | |
| Amgen INC. | $49.60 | 2024-2025 | Tepezza |
| Glaukos Corporation | $49.19 | 2021-2024 | Ce-Marked Kxla System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $34.81 | 2025 | Vevye |
| Shire North American Group INC | $27.22 | 2019 | |
| Rxsight INC | $24.65 | 2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Thea Pharma INC. | $18.25 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Swift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.